DEXWireNews

DEXWireNews

IT IS POSSIBLE THAT GRUB HAS ACTUALLY BUILT A BASE FROM WHICH TO FIND SOME CONSISTENCY IN THE PRICE ACTION. THE NEWS THAT AMZN WOULD NOT BE ENTERING THE SECTOR AS A COMPETITION DID ALSO GIVE THE STOCK A BOOST, BUT COMPETITION IS FIERCE AND PROFITS NON EXISTENT. THE CHART INDICATORS ARE BULLISH AND AS LONG AS $69 HOLDS IT REMAIN SO. AVERAGE ANALYSTS PRICE TARGET...

DEXWireNews

If you fancy a flutter, GERN could be a great place to start, option traders are expecting a move of up to $40 % on Monday as a result of the outcome from the Phase Data results been released tomorrow at the HOC conference. Like any Bio stock it is risky to trade but can be very rewarding,so play carefully. AVERAGE ANALYSTS PRICE TARGET $3.5 AVERAGE ANALYSTS...

DEXWireNews

The first quarter of 2018 AVGO had a similar downbeat report and earnings call, they stock sold of before hitting a all time high 1 year later. This time round the stock has rebounded 5% alone from the pre market lows, and has moved back above the 200ma which is a critical level, if it can close at these levels buyers will flock back in next week if the market...

DEXWireNews

======================== ZNZBF (Zanzibar Gold Inc.) Alert Price: $0.1150 Float: 13.69M Website | Recent News ======================== Members, We plan on ending this already profitable week of trading with something huge! We've just identified an exciting opportunity in the gold sector. We have several reasons to believe that the entire gold...

DEXWireNews

*********This is truly speculative as there is no fundamental reason for this to be attracting attention, but it could very likely spike in the coming days. This is a pre clinical company so news has a major impact on price.***** COMPANY PROFILE Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development,...

DEXWireNews

The stock of NKTR has been setting up nicely for a breakout and June 13th could be the day it happens, as the company will be hosting a analysts conference call to discuss trial results/data. Keep on strong watch for explosive moves. AVERAGE ANALYSTS PRICE TARGET $69.50 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT SHORT INTEREST 12.65% P/E RATIO 9.54 Nektar...

DEXWireNews

*******ALERTED TO CAPR ON SPECULATION AND RUMOR WITH HIGH VOLUME AND PRICE SPIKE TO CONFIRM INTEREST, ON CLOSE WATCH FOR COMING DAYS***** AVERAGE ANALYSTS PRICE TARGET $35 AVERAGE ANALYSTS RECOMMENDATION COMPANY PROFILE Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the...

DEXWireNews

OPTIONS TRADES ARE A PRETTY GOOD TELL ON THE FUTURE OF A STOCK, IN THE CASE OF SNSS OPTIONS TRADED TODAY WERE OF INTEREST GIVEN THE FACT THE COMPANY WILL BE RELEASING DATA IN THE COMING DAYS. WITH A STRIKE PRICE OF $1 THEY PREDICT A UPSIDE POTENTIAL OF 40% BEFORE JUNE 21ST, THAT IS QUITE A NICE RISE FROM THE CURRENT LEVEL AND QUICK GAIN. SOMEONE KNOWS SOMETHING. ...

DEXWireNews

===================== GDET ( GD Entertainment & Technology, Inc.) Alert Price: $0.0069 Chart Analysis Goldman Price Target: $0.06 Goldman Small Cap Research Report Website | Recent News Ecommerce: www.thegreeneryco.com ======================== Members, Earlier today we promised you an explosive subpenny alert with massive upside potential. In...

DEXWireNews Updated 

Sine the 13th may when President and CEO DR Thomas Cannell conducted the company's earnings call, investors are buoyed by what he had to say and the future prospects, with upcoming meetings with the FDA this could be a blowout stock in the weeks to come. Average analyst estimate BUY Average analysts price target $3.50 Company Description Sesen Bio, Inc....

DEXWireNews

*********************BREAKOUT TODAY ON FDA APPROVAL****** Motus GI Holdings, Inc, a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the second-generation Pure-Vu® System (“Pure-Vu® GEN2”) to...

DEXWireNews

********KEEP ON THE WATCHLIST FOR BREAKOUT, IMPROVED TRIAL RESULTS RELEASED, WITH CONFERENCE CALL TO FOLLOW LATER IN THE DAY******* Achieve Life Sciences, Inc. ACHV, clinical-stage pharmaceutical company focused on nicotine addiction, today announced positive results from the ORCA-1 dose-selection trial of cytisinicline for smoking cessation. The outcome of the...

DEXWireNews

*******POSSIBLE BREAKOUT IN BIO STOCK WITH NICE PRICE ACTION, INCREASED INTEREST AMONG TRADERS AS RUMORS AND SPECULATION FOLLOW THIS STOCK, KEEP ON WATCHLIST FOR A RAPID MOVE*************** AVERAGE ANALYSTS PRICE TARGET $9 AVERAGE ANALYSTS RECOMMENDATION BUY COMPANY PROFILE OncoSec Medical, Inc. is a biotechnology company, which engages in...

DEXWireNews

******HOT STOCK ON THE WATCHLIST FOR THEY COMING DAYS, PURE SPECULATION AND RUMOR PICK, UNUSUAL BUY VOLUME AND PRICE SPIKE.********************** COMPANY PROFILE Xenetic Biosciences, Inc. engages in the discovery, research, and development of next generation biologic drugs and novel orphan oncology therapeutics. Its lead investigational product candidate is...

DEXWireNews

Keep on strong watch for continuation in KOOL in the coming days, todays advance was muted by other headline stock movements and strong volume in NDX and DJI. PRESS SOURCE MARKETWATCH Cesca Therapeutics Inc surged 11% in premarket trade Monday, after the provider of automated cell processing and point-of-care, autologous cell-based therapies said its...

DEXWireNews

===================== SPEX ( Spherix Incorporated) Float: 1.98M Alert Price: $2.97 CEO Interview Chart Analysis Website | Recent News ======================== Add SPEX to the top of your watchlist. See why this low-float alert could be the Nasdaq's top gainer Members, Earlier today we told you that we had a fresh low-float, Nasdaq listed...

DEXWireNews

AFTER A UNUSUAL 15% PRICE SPIKE ON FRIDAY ON HIGH VOLUME, THE STOCK OF NASDAQ:MHLD WILL BE ON STRONG WATCH FOR NEXT WEEK . INSIDERS HAVE BEEN BUYING THE STOCK AS HAVE INSTITUTIONAL INVESTORS SINCE LATE 2018. THE CHART IS TECHNICALLY SHOWING BULLISH DIVERGENCE SO KEEP ON THE WATCHLIST WITH ALERTS SET FOR VOLUME AND PRICE SPIKE . AVERAGE ANALYSTS PRICE TARGET ...

DEXWireNews

*****KEEP ON CLOSE WATCH FOR THE WEEKS TO COME FOR MASSIVE BREAKOUT AS A RESULT OF LICENCE APPLICATION******** Protalix BioTherapeutics and Chiesi Farmaceutici S.p.A to Apply for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States "We are very excited to be one step closer to an approved product to help a patient...